Reactive Leukocytosis and Leukopenia

REACTIVE LEUKOCYTOSIS MECHANISMS

• G-CSF and GM-CSF mediated granulopoiesis: Cytokines released during infection, inflammation, or stress stimulate bone marrow progenitor cells (CFU-GM and CFU-G) to undergo accelerated proliferation and differentiation. Tissue macrophages and endothelial cells produce IL-1 and TNF-α, which induce hepatic IL-6 and direct production of G-CSF by fibroblasts and bone marrow stromal cells. This leads to increased myeloid hyperplasia in the bone marrow with leftward shift in maturation (increased bands, metamyelocytes, myelocytes).

• Demargination and release from bone marrow pools: The marginating pool of neutrophils (adherent to vessel endothelium) equals the circulating pool in size; catecholamines (epinephrine) and corticosteroids cause demargination, releasing sequestered neutrophils into the circulation without increased production. This mechanism accounts for rapid leukocytosis in acute stress and exercise.

• Decreased apoptosis and prolonged neutrophil survival: Corticosteroids and inflammatory mediators inhibit neutrophil apoptosis and suppress removal by bone marrow macrophages, extending the circulation time from 6-8 hours to 24+ hours. TNF-α and GM-CSF upregulate anti-apoptotic proteins (Bcl-2 family members) in neutrophil precursors.

• Lymphocyte redistribution and proliferation: Viral infections and stress cause egress of lymphocytes from lymphoid tissues into circulation, while T cell mitogens and B cell activation drive clonal expansion of specific populations. EBV and CMV induce atypical lymphocyte morphology through T cell response activation.

REACTIVE LEUKOPENIA MECHANISMS

• Decreased production (myelosuppression): Medications (chemotherapy, immunosuppressants, antibiotics), radiation, vitamin deficiencies (B12, folate), severe infections overwhelming bone marrow, and infiltrative processes reduce CFU-GM and CFU-G progenitor proliferation. Bone marrow examination reveals hypocellular or aplastic marrow with reduced myeloid precursors. G-CSF depletion occurs with severe sepsis as organisms overwhelm the marrow's capacity to respond.

• Peripheral consumption and sequestration: Splenic sequestration (hypersplenism, portal hypertension) traps neutrophils; bone marrow biopsy shows normal or hyperplastic marrow with appropriate production but decreased peripheral counts. Sepsis consumes neutrophils through margination and tissue infiltration, overwhelming production. Immune-mediated destruction (antibodies, complement) destroys circulating and bone marrow neutrophils in drug-induced immune agranulocytosis.

• Bone marrow infiltration: Malignancy, fibrosis, granulomas, or storage diseases replace normal hematopoietic tissue, reducing granulopoietic space (myelophthisic process). Histology shows absence of normal myeloid maturation replaced by pathologic cells or fibrotic tissue.

• Increased apoptosis and accelerated clearance: Drug-induced immune mechanisms and autoimmune neutropenia cause antibody-mediated complement activation on neutrophil surfaces, promoting destruction. Selective loss of neutrophil precursors occurs with anti-myeloperoxidase (MPO) antibodies.

• Redistributional leukopenia: Acute infections cause margination with tissue infiltration exceeding new production. Acute leukemia paradoxically may present with leukopenia if blasts lodge in marrow, excluding normal granulopoiesis.

CAUSES OF REACTIVE LEUKOCYTOSIS

• Infections: Bacterial (pneumonia, abscess, meningitis), fungal (aspergillosis, candidiasis), some viral (influenza, varicella-zoster), and mycobacterial infections (tuberculosis) trigger robust leukocytosis. Bacterial infections produce the highest WBC counts (often >20,000-50,000/μL) with pronounced left shift. Viral infections may cause modest leukocytosis with lymphocyte predominance or atypical lymphocytes.

• Inflammation and autoimmune diseases: Rheumatoid arthritis, inflammatory bowel disease, vasculitis, and acute rheumatic fever stimulate sustained IL-6 and TNF-α production.

• Tissue necrosis and infarction: Myocardial infarction (within hours), pulmonary embolism, acute hemolysis, and burns cause massive acute neutrophilic release.

• Malignancy (paraneoplastic): Lung, gastric, and renal cell carcinomas produce G-CSF or IL-6. Lymphomas produce IL-6. Often associates with poor prognosis.

• Medications: Corticosteroids (most common cause in hospitalized patients; demargination mechanism), lithium (G-CSF production and decreased apoptosis), epinephrine, G-CSF/GM-CSF (therapeutic or growth factors).

• Metabolic and endocrine disturbances: Thyroid storm, diabetic ketoacidosis, uremia, myxedema, Cushing syndrome.

• Physical and emotional stress: Exercise, seizures, labor, anxiety, and severe pain trigger catecholamine-mediated demargination.

• Smoking: Chronic smokers have constitutively elevated WBC (>1,000 cells/μL higher than non-smokers) due to continuous low-grade inflammatory stimulus.

• Myeloproliferative neoplasms: CML, polycythemia vera, essential thrombocythemia show sustained leukocytosis; differentiated from reactive by presence of Philadelphia chromosome, LAP score, and clonality studies.

CAUSES OF REACTIVE LEUKOPENIA

• Medications:
• Chemotherapy agents (alkylating agents, antimetabolites) cause dose-dependent myelosuppression with nadir typically 7-14 days after administration
• Antibiotics (trimethoprim-sulfamethoxazole, chloramphenicol, penicillins, cephalosporins) cause immune-mediated agranulocytosis with onset 1-4 weeks
• Immunosuppressants (methotrexate, azathioprine, TNF-α inhibitors)
• Anticonvulsants (phenytoin, carbamazepine)
• NSAIDs and acetaminophen (rare but documented)

• Infections:
• Overwhelming sepsis (especially gram-negative, early stages) exhausts bone marrow production
• Viral infections (HIV, CMV, EBV, dengue, measles) suppress marrow and cause sequestration
• Leishmaniasis, tuberculosis, histoplasmosis infiltrate marrow
• Typhoid fever causes selective neutropenia

• Nutritional deficiencies: Vitamin B12 and folate deficiency impair DNA synthesis in myeloid precursors (megaloblastic changes). Copper deficiency (total parenteral nutrition, excessive zinc supplementation).

• Bone marrow disorders:
• Aplastic anemia (autoimmune T cell suppression of hematopoiesis)
• Myelodysplastic syndromes (dysplastic maturation with reduced output)
• Acute leukemia (blast infiltration replacing normal granulopoiesis)
• Myelofibrosis (fibrotic replacement of hematopoietic tissue)

• Splenic sequestration (hypersplenism): Portal hypertension, cirrhosis, massive splenomegaly from any cause traps up to 90% of neutrophils.

• Autoimmune neutropenia: Antibodies against FcγRIIIb (antigen NA1 and NA2), HNA antigens cause complement-mediated destruction. Common in infants (often benign and self-limited) and adults with SLE or rheumatoid arthritis.

• Immune complex-mediated: SLE with anti-myeloperoxidase antibodies; rheumatoid arthritis with Felty syndrome (splenomegaly + neutropenia).

• Ionizing radiation: Occupational, therapeutic, or accidental exposure causes dose-dependent marrow aplasia with latency of days to weeks.

• Infiltrative diseases: Sarcoidosis, tuberculosis, fungal infections, lymphoma, myeloma infiltrate marrow space.

• Drug-induced immune agranulocytosis: Propylthiouracil, methimazole, sulfonamides, phenothiazines trigger IgG antibodies against drug-hapten-neutrophil complexes leading to rapid destruction.

• Idiopathic benign leukopenia: Rare; diagnosis of exclusion after thorough evaluation, often with ethnic variation (African and Middle Eastern populations have lower normal baseline WBC).

REACTIVE LEUKOCYTOSIS

• Symptoms of underlying condition dominate: Fever, productive cough, and pleuritic chest pain (pneumonia); abdominal pain and diarrhea (inflammatory bowel disease); chest pain and dyspnea (myocardial infarction or pulmonary embolism). The leukocytosis itself is typically asymptomatic.

• Physical examination findings reflect etiology: Consolidation on lung auscultation, focal tenderness over infarct, joint swelling and warmth (rheumatoid arthritis), splinter hemorrhages and new murmur (infective endocarditis).

• Morphological correlates on peripheral blood smear:
• Left shift (immature cells): Increased bands, metamyelocytes, myelocytes, and occasional promyelocytes indicate marrow stress response. Döhle bodies (basophilic inclusions in neutrophil cytoplasm) appear with severe infections or sepsis
• Toxic granulations: Coarse azurophilic granules in neutrophil cytoplasm (see below under High-Yield Pearls)
• Cytoplasmic vacuolization: Represents phagocytosed organisms or cellular debris
• Atypical lymphocytes (Downey cells): In viral infections, characterized by abundant cytoplasm, irregular borders, azurophilic granules, and eccentric nuclei mimicking abnormal cells but representing activated cytotoxic T lymphocytes
• Anisopoikilocytosis: RBC variation with associated polychromasia if concurrent hemolysis

• Laboratory and imaging correlates:
• Elevated WBC typically 11,000-20,000/μL in mild infections, 20,000-50,000/μL in severe sepsis; can exceed 100,000/μL with massive tissue necrosis or malignancy-induced leukocytosis
• Elevated serum creatinine, electrolyte abnormalities (myocardial infarction with heart failure)
• Elevated CRP and ESR (inflammation marker elevation proportional to stimulus)
• Imaging abnormalities: Consolidation on chest X-ray, infarct on cardiac MRI, splenic infarction on CT

REACTIVE LEUKOPENIA

• Symptoms of underlying infection or deficiency state: Fever and chills (if leukopenia due to overwhelming infection), bleeding gums or epistaxis (if concurrent thrombocytopenia), recurrent infections (immune dysfunction), glossitis and paresthesias (B12 deficiency), or jaundice (hemolysis).

• Physical examination findings:
• Mucosal ulceration, aphthous stomatitis, and gingivitis: Indicate severe agranulocytosis (WBC <500/μL) with loss of oral barrier defense
• Splenomegaly: Suggests hypersplenism or infiltrative disease; hepatomegaly may accompany both
• Lymphadenopathy: Points toward lymphoproliferative disease or infections (EBV, CMV, tuberculosis)
• Petechiae and ecchymoses: Concurrent thrombocytopenia with bone marrow disorder

• Morphological correlates on peripheral blood smear:
• Reduced neutrophil numbers with relative lymphocytosis (normal absolute lymphocyte count but elevated percentage)
• Left shift absence: Unlike leukocytosis, reactive leukopenia shows normal or immature morphology of remaining neutrophils (no toxic changes) unless from production failure
• Hypersegmented neutrophils (>5 nuclear lobes): Seen with B12 and folate deficiency, representing delayed nuclear maturation
• Atypical lymphocytes: If viral etiology
• Macro-ovalocytes: B12 or folate deficiency with megaloblastic marrow changes

• Laboratory and imaging correlates:
• WBC <4,500/μL, with differential showing neutropenia (absolute neutrophil count <1,500/μL in mild, <500/μL in severe agranulocytosis)
• Absolute lymphocyte and monocyte counts usually normal or elevated (revealing the neutropenia)
• Bone marrow examination (when indicated):
• Aplastic anemia: hypocellular marrow with <25% cellularity, absent myeloid series
• Myelodysplasia: dysplastic changes in myeloid lineage with abnormal nuclear-cytoplasmic ratio, abnormal chromatin, and decreased maturation
• Megaloblastic changes: nuclear-cytoplasmic dissociation with immature nuclear chromatin despite cytoplasmic maturity (from B12/folate deficiency)
• Infiltrative disease: abnormal infiltrate replacing normal hematopoietic tissue
• Elevated indirect bilirubin and LDH (if hemolysis concurrent)
• Elevated creatinine (if renal disease or severe sepsis)
• Serum B12 and folate levels (if deficiency suspected)
• Imaging: Chest X-ray for infiltrates (infection, malignancy), abdominal ultrasound/CT for splenic size (hypersplenism), splenomegaly on exam

DIAGNOSTIC APPROACH

STEP 1: Verify absolute counts and obtain differential

• Confirm WBC count and request complete differential (% neutrophils, lymphocytes, monocytes, eosinophils, basophils)
• Calculate absolute neutrophil count (ANC) = (% neutrophils + % bands) × WBC
• Request peripheral blood smear for morphologic assessment

STEP 2: Obtain clinical history and physical examination

• Recent infections, fever, chills, weight loss, sweats, bleeding
• Medication review (chemotherapy, antibiotics, immunosuppressants, NSAIDs, anticonvulsants)
• Nutritional assessment (diet, alcohol use, pernicious anemia risk)
• Family history of hematologic disorders
• Exposure history (radiation, toxins, chemicals)
• Examine for infection foci, splenomegaly, lymphadenopathy, petechiae, mucositis

STEP 3: Initial laboratory studies

• CBC with differential and peripheral smear interpretation:
• Leukocytosis: Assess degree of elevation, presence of left shift (bands, metamyelocytes), toxic granulations, Döhle bodies, or atypical lymphocytes
• Leukopenia: Identify which cell line is decreased (neutropenia vs. lymphopenia vs. monocytopenia); assess morphology

Immediate stabilization — febrile neutropenia is the emergency

• Empiric antibiotics within 1 hour: Per the IDSA guideline on antimicrobial use in neutropenic patients with cancer, fever (single temperature ≥38.3°C or ≥38.0°C sustained an hour) with ANC <500/μL mandates blood cultures from all lumens and a peripheral site, then immediate antipseudomonal beta-lactam monotherapy — cefepime, piperacillin-tazobactam, or a carbapenem such as meropenem. Do not delay antibiotics for imaging or culture results.
• Add gram-positive coverage selectively: Vancomycin is not routine; IDSA reserves it for hemodynamic instability, suspected catheter-related infection, skin/soft-tissue infection, pneumonia, or known MRSA colonization. Dose to a 24-hour AUC/MIC of 400–600 per the 2020 IDSA/ASHP/PIDS/SIDP consensus, not to a trough.
• Risk-stratify: Low-risk patients (MASCC score, anticipated short neutropenia) may receive oral fluoroquinolone plus amoxicillin-clavulanate as outpatients under IDSA criteria.

Directed and second-line therapy

• Stop the culprit drug: In drug-induced agranulocytosis (methimazole/propylthiouracil, clozapine, TMP-SMX, ticlopidine), withdrawal is definitive; counts typically recover over one to three weeks.
• Myeloid growth factors: G-CSF (filgrastim, pegfilgrastim) is recommended by ASCO and NCCN as primary prophylaxis when a chemotherapy regimen carries roughly a 20% or higher febrile-neutropenia risk, not as routine adjunctive therapy for uncomplicated established febrile neutropenia.
• Replete deficiencies: Vitamin B12 or folate for megaloblastic neutropenia; copper for TPN- or zinc-associated cytopenia.
• Antifungal escalation: Persistent fever beyond four to seven days on broad-spectrum antibacterials prompts empiric mold-active therapy (echinocandin or lipid amphotericin) per IDSA.

Contraindicated / avoid

• Rechallenge with the offending drug after immune agranulocytosis.
• Rectal thermometers, suppositories, and digital rectal exams in profound neutropenia (mucosal translocation risk).
• Corticosteroids as "treatment" for leukocytosis — they raise the count and blunt fever, masking sepsis.

Complications of the underlying disorder

• Overwhelming sepsis with leukopenia (emergency): Consumption and marrow exhaustion outpace production; a falling WBC with bandemia, toxic granulation, and Döhle bodies in a septic patient is an ominous marker of severe disease, not reassurance.
• **Neutropenic enterocolitis (typhlitis)** (emergency): Loss of mucosal neutrophil defense permits transmural bowel invasion; right lower quadrant pain, fever, and diarrhea with cecal wall thickening on CT. Perforation is the feared endpoint; surgical consultation is required.
• Invasive fungal infection: Neutropenia lasting beyond about a week favors Aspergillus (halo sign, then air-crescent sign on chest CT) and invasive candidiasis; persistent fever despite broad-spectrum antibacterials is the signal.
• Bacteremia from gut translocation: Chemotherapy mucositis plus neutropenia allows viridans streptococci and gram-negative rods into the bloodstream.
• Oral ulceration and necrotizing gingivitis: Direct consequence of agranulocytosis; painful aphthous lesions without surrounding erythema (no neutrophils to make pus).
• Missed clonal disease: A sustained "reactive" leukocytosis that is actually CML or a myelodysplastic syndrome; look for basophilia, absolute monocytosis, splenomegaly, or a leukoerythroblastic smear (teardrop cells plus nucleated RBCs) signaling marrow infiltration.

Complications of treatment

• ***Clostridioides difficile* colitis**: Broad-spectrum beta-lactam exposure; watery diarrhea with leukocytosis that may reach leukemoid range.
• Vancomycin-associated acute kidney injury: Risk rises with concurrent piperacillin-tazobactam; rising creatinine on therapy.
• Beta-lactam hypersensitivity: In documented penicillin allergy, cephalosporin cross-reactivity is roughly 1–3% and is driven by shared R1 side chains rather than the beta-lactam ring — cefepime is commonly used safely; the historical 10% figure is obsolete.
• G-CSF toxicity: Cytokine-driven marrow expansion causes bone pain; rare splenic rupture (emergency — left upper quadrant pain, hypotension), capillary leak, ARDS, and Sweet syndrome (neutrophilic dermatosis).
• Masked infection on corticosteroids: Steroid-induced demargination raises the WBC while suppressing fever and CRP, delaying recognition of perforation or abscess.

• Leukemoid reaction vs CML: WBC >50,000/μL with marked left shift, toxic granulation, and Döhle bodies is a leukemoid reaction with a high leukocyte alkaline phosphatase (LAP) score. CML has a low LAP, absolute basophilia, and BCR-ABL1 by FISH/PCR — the single best confirmatory test. LAP is the classic exam discriminator even though modern labs favor molecular testing.
• Steroid signature: Corticosteroids produce neutrophilia with lymphopenia and eosinopenia via demargination and lymphocyte redistribution. Infection raises neutrophils but does not typically drive eosinophils to zero — that triad points to steroids, not sepsis.
• **Atypical lymphocytes (Downey cells) are reactive CD8+ T cells, not infected B cells** — the classic EBV trap. Heterophile (Monospot) antibody confirms; the association examiners love is the morbilliform rash after amoxicillin/ampicillin, and the management point is avoiding contact sports for splenic rupture risk.
• Absolute vs relative: Always calculate ANC = WBC × (% neutrophils + % bands). Neutropenia with a high percentage of lymphocytes is relative lymphocytosis — the absolute lymphocyte count is normal. This is the most common distractor in leukopenia stems.
• Benign ethnic neutropenia (Duffy-null–associated): Mild chronic neutropenia in persons of African ancestry with no increased infection risk; do not order a bone marrow biopsy or withhold chemotherapy for it.
• Best next step in fever + ANC <500/μL: Blood cultures then an antipseudomonal beta-lactam within one hour (IDSA). Not CT first, not "observe," not G-CSF.
• Pertussis causes a striking absolute lymphocytosis without atypical forms; Bordetella toxin blocks lymphocyte egress from the circulation.
• Leukoerythroblastic smear (teardrop RBCs, nucleated RBCs, immature myeloid cells) means marrow infiltration or fibrosis, not a reactive process — proceed to bone marrow biopsy.